Company intelligence / Profile preview

EndyMed

Caesarea, Haifa, Israelendymed.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

EndyMed’s proprietary FDA-cleared “3DEEP” radiofrequency platform powers a suite of professional and home-use energy-based aesthetic devices. Clinical results demonstrate efficacy in non-invasive wrinkle treatment, skin tightening on face/body, body contouring and acne scar treatment. The company’s NEWA home-use RF device was the first FDA-cleared for at-home wrinkle reduction.[4]

Therapeutic areas: Dermatology
Modalities: Device (energy-based medical aesthetic devices)Radiofrequency device (3DEEP RF technology)Microneedle device (RF microneedling)Laser device (hair removal and resurfacing lasers)
Industry: Therapeutic Medical Devices

Partnerships

Shanghai Haohai Biological Technology Co., Ltd. (distribution/ownership)global network of distributors.

Beyond the preview

Go deeper on EndyMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EndyMed.

Explore the full profile